This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Other endocrine disorders
  • /
  • Once-monthly injection of pasireotide LAR reduces ...
Journal

Once-monthly injection of pasireotide LAR reduces urinary free cortisol (UFC) levels in patients with Cushing's disease: Results from a randomised, multicentre, phase III trial

Read time: 1 mins
Published:25th Mar 2020
Author: John Newell-Price, Stephan Petersenn, Beverly M K Biller, Michael Roughton, Shoba Ravichandran, André Lacroix
Availability: Free full text
Ref.:Endocrine Abstracts (2016) 41 GP153
DOI:10.1530/endoabs.41.GP153
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest